Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
3-Hydroxybutyrate (BHBA): From Metabolite to Mechanism
2026-09-30
3-hydroxybutyrate (BHBA) is more than a ketosis marker: it is a metabolic, membrane-active, and epigenetic research probe. This article presents an assay-centered framework for separating direct BHBA effects from broader ketone-body and ischemic-conditioning responses.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-09-30
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer-cell proliferation, and metabolic responses. It is appropriate for mechanistic preclinical workflows but should not be used to support clinical efficacy conclusions or protocols requiring aqueous or ethanol solubility.
-
DeferoxamineB in Iron-Dependent Cancer Assays
2026-09-29
DeferoxamineB provides a controllable iron-chelation axis for separating iron-dependent stress from copper-associated, apoptotic, and autophagic effects in cancer models. This workflow shows how to combine dose-response testing, orthogonal cell-death readouts, and metabolic controls without mistaking chelation-based rescue for proof of a single death pathway.
-
Sulfo-NHS-SS-Biotin for GlycoRNA Surface Maps
2026-09-29
Discover how Sulfo-NHS-SS-Biotin can support reversible cell-surface protein profiling around glycoRNA–RNA-binding protein domains. This article translates recent surface-biology findings into assay design, controls, and interpretation strategies for more defensible interactome studies.
-
Ciprofloxacin in Plasmid-Mediated AMR Research
2026-09-28
Ciprofloxacin can do more than benchmark antibacterial activity: it can help researchers separate resistance phenotype, gene carriage, plasmid transfer, and clonal spread. This article translates recent carbapenem-resistant Enterobacter cloacae findings into a practical assay-design framework.
-
Vincristine Sulfate: Practical Cancer Assay Guide
2026-09-28
Use Vincristine sulfate to probe microtubule disruption and antiproliferative responses across cancer models, with a workflow that separates drug handling, dose selection, and orthogonal readouts. The guide turns reported potency into a practical starting point while emphasizing vehicle controls, model-specific optimization, and limits on cross-domain interpretation.
-
Mitochondrial Calcium Signaling Represses Ferroptosis
2026-09-27
The study links mitochondrial calcium uptake through MCU to acetyl-CoA-dependent GPX4 acetylation, identifying a metabolic route that sustains resistance to ferroptotic cell death. Its mouse, mechanistic, and tumor-model findings suggest testable connections between mitochondrial metabolism and ferroptosis, while leaving the clinical and compound-specific implications open.
-
Vincristine sulfate: Reliable Assay Design
2026-09-26
A scenario-driven guide to using Vincristine sulfate (SKU A1765) in cell viability, proliferation, and cytotoxicity workflows. It explains how to design cell-specific dose responses, prepare stocks, interpret assay endpoints, and assess product options without treating a single benchmark as universal.
-
Ethacridine Lactate Monohydrate in Assay Design
2026-09-25
Ethacridine lactate monohydrate can support research workflows that require antiseptic activity, but its role must be separated from the biology being measured. This article connects practical reagent controls with YAP–TEAD super-enhancer research to help researchers protect causal interpretation in cell-differentiation assays.
-
Deep Learning Screens iPSC Cardiomyocytes for Cardiotoxicity
2026-09-25
Grafton and colleagues combined induced pluripotent stem cell-derived cardiomyocytes with deep-learning analysis of high-content images to identify compounds associated with cardiotoxic phenotypes. Screening a bioactive library and a separate set of molecules with unknown targets showed how a compact image-based score can support early toxicity triage, while leaving clinical risk prediction and mechanism-specific follow-up to further testing.
-
Sumatriptan’s Anti-Inflammatory Evidence: A Review
2026-09-24
Ala and colleagues systematically reviewed evidence that sumatriptan may influence inflammatory signaling beyond its established use in migraine, including effects on cytokines, nitric oxide pathways, and CGRP release. Their synthesis highlights promising protection across experimental injury models, while the mainly preclinical evidence and variation among studies mean that these findings do not establish new clinical indications.
-
T0070907 for Testing PPARγ in Vascular SASP
2026-09-24
T0070907 is a potent PPARγ antagonist that can help researchers test whether PPARγ activity contributes to anti-inflammatory signaling in foam cells. This article translates recent RXRα/PPARγ/NEDD4 findings into a careful assay strategy, emphasizing causal interpretation, species limits, and orthogonal validation.
-
3-Hydroxybutyrate (BHBA) for Stroke Assays
2026-09-23
Use 3-hydroxybutyrate (BHBA) to test whether a defined ketone-body signal can support neuronal resilience during ischemia-like stress. This practical guide separates BHBA-specific effects from mixed-ketone findings and pairs dose selection with ferroptosis-focused readouts and troubleshooting.
-
Vitamin C: Redox Logic for Senescence Assays
2026-09-23
Vitamin C is a context-dependent redox regulator with distinct effects in tumor and cochlear cell models. This article translates ROS/NF-κB evidence into practical assay decisions, dose interpretation, and translational limits.
-
Fiber Density Reconstructs Annulus Fibrosus Collagen
2026-09-22
The reference study shows that fiber density in otherwise composition-matched electrospun scaffolds can direct annulus fibrosus cell phenotypes toward collagen type I- or collagen type II-rich matrix programs. Its mechanistic findings connect scaffold microarchitecture with RhoA–ROCK, ERK/AKT, and Piezo1-associated signaling, offering a design principle for rebuilding the native collagen heterogeneity of the annulus fibrosus.